Dr. Anasuya Gunturi
Claim this profileLowell General Hospital
Studies Cancer
Studies Breast Cancer
8 reported clinical trials
20 drugs studied
Area of expertise
1Cancer
HER2 positive
Stage III
Stage IV
2Breast Cancer
HER2 positive
ER positive
ER negative
Affiliated Hospitals
Clinical Trials Anasuya Gunturi is currently running
Pre- and Post-Surgery Chemotherapy
for Gallbladder Cancer
This phase II/III trial compares the effect of adding chemotherapy before and after surgery versus after surgery alone (usual treatment) in treating patients with stage II-III gallbladder cancer. Chemotherapy drugs, such as gemcitabine and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving chemotherapy before surgery may make the tumor smaller; therefore, may reduce the extent of surgery. Additionally, it may make it easier for the surgeon to distinguish between normal and cancerous tissue. Giving chemotherapy after surgery may kill any remaining tumor cells. This study will determine whether giving chemotherapy before surgery increases the length of time before the cancer may return and whether it will increase a patient's life span compared to the usual approach.
Recruiting1 award Phase 2 & 315 criteria
Chemotherapy Reduction After Surgery
for Breast Cancer
This trial studies how well paclitaxel, trastuzumab, and pertuzumab work in eliminating further chemotherapy after surgery in patients with HER2-positive stage II-IIIa breast cancer who have no cancer remaining at surgery (either in the breast or underarm lymph nodes) after pre-operative chemotherapy and HER2-targeted therapy. Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Trastuzumab and pertuzumab are both a form of "targeted therapy" because they work by attaching themselves to specific molecules (receptors) on the surface of tumor cells, known as HER2 receptors. When these drugs attach to HER2 receptors, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Giving paclitaxel, trastuzumab, and pertuzumab may enable fewer chemotherapy drugs to be given without compromising patient outcomes compared to the usual treatment.
Recruiting1 award Phase 227 criteria
More about Anasuya Gunturi
Clinical Trial Related3 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Anasuya Gunturi has experience with
- Cisplatin
- Paclitaxel
- Pembrolizumab
- Carboplatin
- Trastuzumab
- Pertuzumab
Breakdown of trials Anasuya Gunturi has run
Cancer
Breast Cancer
Breast cancer
Endometrial Cancer
Serous Cystadenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Anasuya Gunturi specialize in?
Anasuya Gunturi focuses on Cancer and Breast Cancer. In particular, much of their work with Cancer has involved HER2 positive patients, or patients who are Stage III.
Is Anasuya Gunturi currently recruiting for clinical trials?
Yes, Anasuya Gunturi is currently recruiting for 4 clinical trials in Lowell Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Anasuya Gunturi has studied deeply?
Yes, Anasuya Gunturi has studied treatments such as Cisplatin, Paclitaxel, Pembrolizumab.
What is the best way to schedule an appointment with Anasuya Gunturi?
Apply for one of the trials that Anasuya Gunturi is conducting.
What is the office address of Anasuya Gunturi?
The office of Anasuya Gunturi is located at: Lowell General Hospital, Lowell, Massachusetts 01854 United States. This is the address for their practice at the Lowell General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.